| Name | Adcy5 |
|---|---|
| Description | adenylate cyclase 5 |
| Notes | ADCY5 belongs to the adenylate cyclase (EC 4.6.1.1) family of enzymes responsible for the synthesis of cAMP (Ludwig and Seuwen, 2002 [PubMed 12503609]).[supplied by OMIM] |
| Owner | Public |
| URN | urn:agi-llid:111 |
| Connectivity | 65 |
| LocusLink ID | 111 |
|---|---|
| 224129 | |
| 64532 |
| OMIM ID | 600293 |
|---|
| GO ID | 0004016 |
|---|---|
| 0000287 | |
| 0001973 | |
| 0006171 | |
| 0007191 | |
| 0007195 | |
| 0007242 | |
| 0007626 | |
| 0050885 | |
| 0016021 | |
| 0005886 | |
| 0016829 | |
| 0046872 | |
| 0016849 | |
| 0007189 | |
| 0009190 | |
| 0016020 | |
| 0044424 | |
| 0005624 | |
| 0042383 |
| Hugo ID | 236 |
|---|
| Human chromosome position | 3q13.2-q21 |
|---|
| Unigene ID | Hs.593293 |
|---|---|
| Hs.655144 | |
| Mm.41137 | |
| Rn.6278 |
| KEGG ID | hsa:111 |
|---|---|
| mmu:224129 | |
| rno:64532 |
| Alias | AC5 |
|---|---|
| adenylate cyclase 5 | |
| adenylate cyclase, type V | |
| AW121902 | |
| adenylyl cyclase type V | |
| LOC224129 | |
| ADCY5 | |
| hypothetical protein LOC224129 | |
| expressed sequence AW121902 | |
| adenylyl cyclase 5 | |
| AC 5 | |
| AC-5 | |
| AC(5) |
| Organism | Homo sapiens |
|---|---|
| Mus musculus | |
| Rattus norvegicus |
| Mouse chromosome position | 16 B-5 |
|---|
| Rat chromosome position | 11q22 |
|---|
| Cell Localization | Cytoplasm |
|---|
| Homologene ID | 11213 |
|---|
| Pathway | glucagon signaling pathway |
|---|
| MGI ID | 99673 |
|---|
| Ariadne Ontology | ADCY |
|---|
| RGD ID | 71014 |
|---|
| GO Molecular Function | metal ion binding |
|---|---|
| magnesium ion binding | |
| lyase activity | |
| adenylate cyclase activity | |
| phosphorus-oxygen lyase activity |
| GO Cellular Component | intracellular part |
|---|---|
| membrane | |
| membrane fraction | |
| plasma membrane | |
| integral to membrane | |
| sarcolemma |
| GO Biological Process | intracellular signaling cascade |
|---|---|
| adenosine receptor signaling pathway | |
| dopamine receptor, adenylate cyclase activating pathway | |
| dopamine receptor, adenylate cyclase inhibiting pathway | |
| G-protein signaling, adenylate cyclase activating pathway | |
| cyclic nucleotide biosynthetic process | |
| cAMP biosynthetic process | |
| neuromuscular process controlling balance | |
| locomotory behavior |
| Group | intracellular part |
|---|---|
| membrane | |
| membrane fraction | |
| plasma membrane | |
| integral to membrane | |
| sarcolemma | |
| metal ion binding | |
| magnesium ion binding | |
| lyase activity | |
| adenylate cyclase activity | |
| phosphorus-oxygen lyase activity | |
| intracellular signaling cascade | |
| adenosine receptor signaling pathway | |
| dopamine receptor, adenylate cyclase activating pathway | |
| dopamine receptor, adenylate cyclase inhibiting pathway | |
| G-protein signaling, adenylate cyclase activating pathway | |
| cyclic nucleotide biosynthetic process | |
| cAMP biosynthetic process | |
| neuromuscular process controlling balance | |
| locomotory behavior | |
| ADCY |